NCT04393350 2026-04-20Perioperative Lenvatinib With Pembrolizumab in Patients With Locally Advanced Nonmetastatic Clear Cell Renal Cell CarcinomaEmory UniversityPhase 2 Active not recruiting18 enrolled 12 charts
NCT06962787 2025-11-17A Study of BL-B01D1+TKI±Pembrolizumab in Patients With Locally Advanced or Metastatic Renal CancerSichuan Baili Pharmaceutical Co., Ltd.Phase 2 Recruiting260 enrolled